Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Banking & Finance  -  Page 185

Montecito Bank & Trust
Latest

Revenues at Santa Barbara’s QAD down for third quarter

By   /  Wednesday, November 25th, 2015  /  Earnings, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Revenues at Santa Barbara’s QAD down for third quarter

Santa Barbara software developer QAD Inc. saw revenues decrease slightly in the third quarter of fiscal year 2016. Revenues at QAD decreased from $74 million to $68 million. Net income for the company was $2.6 million, or 14 cents per share. That missed analyst estimates of 18 cents per share. In recent years, QAD has Read More →

Read More →
Latest

Sientra collapse doomed execs

By   /  Friday, November 20th, 2015  /  Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Sientra collapse doomed execs

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Semtech third quarter earnings per share miss estimate

By   /  Thursday, November 19th, 2015  /  Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Semtech third quarter earnings per share miss estimate

Semtech, a Camarillo-based maker of semiconductors for cell phones and electronic devices, missed analyst estimates slightly when the company reported third quarter results Nov. 18. Semtech reported earnings per share of 16 cents. Analysts had expected earnings per share of 24 cents. Semtech slightly exceeded analyst revenue estimates of $115.4 million by posting earnings of Read More →

Read More →
Latest

Goleta-based Sientra’s third quarter revenues down

By   /  Monday, November 16th, 2015  /  Central Coast Health Watch, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Goleta-based Sientra’s third quarter revenues down

Sientra Inc. sales were down 6.9 percent in the third quarter of 2015 but the results were largely unaffected by recent pandemonium at the company. The Goleta-based company reported third quarter results on Nov. 16 for the quarter that ended on Sept. 30, just one week after European regulators pulled products made by Sientra’s Brazilian Read More →

Read More →
Latest

Goleta breast implant maker Sientra shakes up C-Suite

By   /  Thursday, November 12th, 2015  /  Central Coast Health Watch, Latest news, South Coast, Top Stories, Tri-County Public Companies  /  Comments Off on Goleta breast implant maker Sientra shakes up C-Suite

  The writing was on the wall at Sientra. On Nov. 12, the company’s top executives took the fall. The embattled Goleta-based breast implant manufacturer cleaned house Thursday afternoon. Sientra founder and CEO Hani Zeini stepped down as CEO and he will be replaced by industry veteran Jeffrey Nugent. Nicholas Simon also resigned as chairman Read More →

Read More →
Latest

Inogen’s third quarter earnings beat Wall Street expectations

By   /  Wednesday, November 11th, 2015  /  Central Coast Health Watch, Earnings, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Inogen’s third quarter earnings beat Wall Street expectations

  Inogen, a Goleta-based maker of direct-to-consumer respiratory products, beat analyst estimates for revenue when the company released third quarter earnings on Nov. 10. Revenues were up 38.7 percent from $29.4 million during the third quarter of last year to $40.8 million this year. Analysts had predicted revenues of $37 million. Inogen also reported adjusted Read More →

Read More →
Latest

Port Hueneme’s Stellar Biotechnologies trading on Nasdaq

By   /  Friday, November 6th, 2015  /  Latest news, Technology, Tri-County Public Companies, West Ventura County  /  Comments Off on Port Hueneme’s Stellar Biotechnologies trading on Nasdaq

Port Hueneme-based Stellar Biotechnologies started trading on the Nasdaq stock exchange Nov. 5. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. Shares opened at $8.74 on Nov. 5 and were trading on the Nasdaq at $9.40 as of 11:30 Read More →

Read More →